
BioMarin Pharmaceutical (NASDAQ: BMRN)
BioMarin Pharmaceutical Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
BioMarin Pharmaceutical Company Info
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
News & Analysis
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
BioMarin: EPS Surges Past Expectations
BioMarin Pharmaceutical exceeded earnings and revenue expectations in its Q4 2024 financial results.
BioMarin Reports 28% Jump in Revenue
The midcap biotech delivered solid Q3 results, driven by strong demand for rare genetic disorder therapies.
BioMarin: Q2 Revenue Soars 20%
BioMarin Pharmaceutical reported robust Q2 2024 financial results, driven by strong revenue growth and key product success.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Why BioMarin Pharmaceuticals Fell 6.9% on Thursday
Investors were expecting better top-line numbers from the company's earnings report.
Why BioMarin Pharmaceutical Tumbled on Thursday
While the company broadly met expectations for the fourth quarter, investors seemed concerned about its 2022 guidance.
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
The rare-disease specialist might now have a true franchise-level drug following the approval of Voxzogo.
Valuation
Earnings Transcripts
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
BMRN earnings call for the period ending September 30, 2021.
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
BMRN earnings call for the period ending June 30, 2021.
Biomarin Pharmaceutical Inc (BMRN) Q1 2021 Earnings Call Transcript
BMRN earnings call for the period ending March 31, 2021.
Biomarin Pharmaceutical Inc (BMRN) Q4 2020 Earnings Call Transcript
BMRN earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.